Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Murphy

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Lipids|April 1, 1987
Hepatic lipid abnormalities in a chemical/viral mouse model for Reye's syndromeM G Murphy, L Archambault-Schertzer, J VanKessel, et al.
Biopharmaceutics & Drug Disposition|August 28, 2001
Pharmacokinetic assessment of an oral enalapril suspension for use in childrenR K Rippley, J Connor, J Boyle, et al.
Chemosphere|February 22, 2005
Two formulations of the industrial surfactant, Toximul, differentially reduce mouse weight gain and hepatic glycogen in vivo during early development: effects of exposure to Influenza B VirusM G Murphy, M Al-Khalidi, J F S Crocker, et al.
Veterinary Parasitology|May 29, 2002
Evaluation of the comparative efficacy of selamectin against flea (Ctenocephalides felis felis) infestations on dogs and cats in simulated home environmentsL K Ritzhaupt, T G Rowan, R L Jones, et al.
American Journal of Obstetrics and Gynecology|January 1, 1990
Predicting neonatal morbidity after perinatal asphyxia: a scoring systemR J Portman, B S Carter, M S Gaylord, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic womenM G Murphy, S Weiss, M McClung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 1999
Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study GroupM G Murphy, M A Bach, D Plotkin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolismM G Murphy, L M Plunkett, B J Gertz, et al.
Journal of Reproduction and Fertility|July 1, 1991
Effect of dietary intake on pattern of growth of dominant follicles during the oestrous cycle in beef heifersM G Murphy, W J Enright, M A Crowe, et al.
Veterinary Parasitology|August 15, 2000
Efficacy of selamectin in the treatment and prevention of flea (Ctenocephalides felis felis) infestations on dogs and cats housed in simulated home environmentsD J Shanks, T G Rowan, R L Jones, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Lipids|April 1, 1987
Hepatic lipid abnormalities in a chemical/viral mouse model for Reye's syndromeM G Murphy, L Archambault-Schertzer, J VanKessel, et al.
Biopharmaceutics & Drug Disposition|August 28, 2001
Pharmacokinetic assessment of an oral enalapril suspension for use in childrenR K Rippley, J Connor, J Boyle, et al.
Chemosphere|February 22, 2005
Two formulations of the industrial surfactant, Toximul, differentially reduce mouse weight gain and hepatic glycogen in vivo during early development: effects of exposure to Influenza B VirusM G Murphy, M Al-Khalidi, J F S Crocker, et al.
Veterinary Parasitology|May 29, 2002
Evaluation of the comparative efficacy of selamectin against flea (Ctenocephalides felis felis) infestations on dogs and cats in simulated home environmentsL K Ritzhaupt, T G Rowan, R L Jones, et al.
American Journal of Obstetrics and Gynecology|January 1, 1990
Predicting neonatal morbidity after perinatal asphyxia: a scoring systemR J Portman, B S Carter, M S Gaylord, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic womenM G Murphy, S Weiss, M McClung, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 1999
Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study GroupM G Murphy, M A Bach, D Plotkin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolismM G Murphy, L M Plunkett, B J Gertz, et al.
Journal of Reproduction and Fertility|July 1, 1991
Effect of dietary intake on pattern of growth of dominant follicles during the oestrous cycle in beef heifersM G Murphy, W J Enright, M A Crowe, et al.
Veterinary Parasitology|August 15, 2000
Efficacy of selamectin in the treatment and prevention of flea (Ctenocephalides felis felis) infestations on dogs and cats housed in simulated home environmentsD J Shanks, T G Rowan, R L Jones, et al.
Pageof 9